BUB1B and hepatocellular carcinoma: BUB1B was shown to be elevated in HCC tissues as well as HCC cell lines, BUB1B overexpression and unfavorable clinicopathological characteristics were positively correlated; in addition, lower recurrence-free and overall survival rates were linked to BUB1B overexpression in HCC patients, per survival studies [30].